<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Polymorphisms in Turkish population &#187; population</title>
	<atom:link href="http://polymorphisms.info/tag/population/feed" rel="self" type="application/rss+xml" />
	<link>http://polymorphisms.info</link>
	<description></description>
	<lastBuildDate>Thu, 19 May 2011 20:57:51 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Analysis of transforming growth factor beta 1 (TGF-beta1) gene polymorphisms in Turkish patients with scleroderma.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/analysis-of-transforming-growth-factor-beta-1-tgf-beta1-gene-polymorphisms-in-turkish-patients-with-scleroderma.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/analysis-of-transforming-growth-factor-beta-1-tgf-beta1-gene-polymorphisms-in-turkish-patients-with-scleroderma.html#comments</comments>
		<pubDate>Fri, 23 Jul 2010 14:05:52 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[Abstract]]></category>
		<category><![CDATA[ACE]]></category>
		<category><![CDATA[Biochem]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[control group]]></category>
		<category><![CDATA[gene polymorphism]]></category>
		<category><![CDATA[Genetic]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[genotype frequencies]]></category>
		<category><![CDATA[increase]]></category>
		<category><![CDATA[Istanbul]]></category>
		<category><![CDATA[patient]]></category>
		<category><![CDATA[PCR]]></category>
		<category><![CDATA[polymorphic]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[Turk]]></category>
		<category><![CDATA[Turkey]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=323</guid>
		<description><![CDATA[Cell Biochem Funct. 2010 Jun;28(4):274-7.
Büyük U, Ates O, Dalyan L, Müsellim B, Ongen G, Topal-Sarikaya A.
Department of Molecular Biology and Genetics, Istanbul University, Turkey. atopal@istanbul.edu.tr

Abstract
Systemic sclerosis (SSc) is an autoimmune disease characterized by inflammation and fibrosis of the skin and visceral organs. Fibrosis associated with SSc is characterized by an increased synthesis of a wide [...]]]></description>
			<content:encoded><![CDATA[<p>Cell Biochem Funct. 2010 Jun;28(4):274-7.</p>
<p>Büyük U, Ates O, Dalyan L, Müsellim B, Ongen G, Topal-Sarikaya A.</p>
<p>Department of Molecular Biology and Genetics, Istanbul University, Turkey. atopal@istanbul.edu.tr</p>
<div>
<h3>Abstract</h3>
<p>Systemic sclerosis (SSc) is an autoimmune disease characterized by inflammation and fibrosis of the skin and visceral organs. Fibrosis associated with SSc is characterized by an increased synthesis of a wide range of extracellular matrix (ECM). TGF-beta is a pluripotent cytokine in a wide range of cell types. In particular it has been found to be a potent inducer of ECM protein synthesis and fibroblast migration. The TGF-beta1 gene is highly polymorphic and two signal sequence polymorphisms at codon 10 and codon 25 are linked to disease outcomes. In this study, we analysed two polymorphic sites of the TGF-beta1 gene, codon 10 and codon 25, in 43 Turkish SSc female patients with interstitial lung involvement and in 75 healty individuals by ARMS-PCR. In our study no significant difference was found in codon 10, codon 25 genotype frequencies between patient with SSc and the control group (p = 0.676, 0.375, respectively). Our findings suggest that codon 10 and 25 polymorphism cannot be related with SSc for Turkish population. 2010 John Wiley &amp; Sons, Ltd.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/analysis-of-transforming-growth-factor-beta-1-tgf-beta1-gene-polymorphisms-in-turkish-patients-with-scleroderma.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Melanocortin-4 Receptor Polymorphisms in Turkish Pediatric Obese Patients.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/melanocortin-4-receptor/melanocortin-4-receptor-polymorphisms-in-turkish-pediatric-obese-patients.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/melanocortin-4-receptor/melanocortin-4-receptor-polymorphisms-in-turkish-pediatric-obese-patients.html#comments</comments>
		<pubDate>Fri, 23 Jul 2010 14:03:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Melanocortin-4 Receptor]]></category>
		<category><![CDATA[akar]]></category>
		<category><![CDATA[appl]]></category>
		<category><![CDATA[control groups]]></category>
		<category><![CDATA[family history group]]></category>
		<category><![CDATA[lys]]></category>
		<category><![CDATA[mutations]]></category>
		<category><![CDATA[obese children]]></category>
		<category><![CDATA[obesity]]></category>
		<category><![CDATA[participants]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=321</guid>
		<description><![CDATA[Clin Appl Thromb Hemost. 2010 Jun 7.
Demiralp DO, Berberoglu M, Akar N.

Abstract
The most common Melanocortin-4 receptor (MC4R) missense variant Val103Ileu (rs2229616) is related to obesity. In this study, we examined the distribution of MC4R polymorphisms both in the clinical pediatric obese group and in the high/low-socioeconomic school group. 24 probable exogene obese children without family [...]]]></description>
			<content:encoded><![CDATA[<p>Clin Appl Thromb Hemost. 2010 Jun 7.</p>
<p>Demiralp DO, Berberoglu M, Akar N.</p>
<div>
<h3>Abstract</h3>
<p>The most common Melanocortin-4 receptor (MC4R) missense variant Val103Ileu (rs2229616) is related to obesity. In this study, we examined the distribution of MC4R polymorphisms both in the clinical pediatric obese group and in the high/low-socioeconomic school group. 24 probable exogene obese children without family history (group I), 66 probable familial obese children (group II), and 111 complicated obese children (group III) were included. Groups I and II obese participants were gathered in a school-based epidemiologic study and compared with 49 apparently healthy non-obese controls. Significant difference in genotype distribution was observed between the groups I and II. Val 103 Ile polymorphism was more common among group III (4.5%). Furthermore, we detected Glu 42 Lys (18.18%) polymorphism in our population, which was not previously reported. Frequency of Val 103 Ile (A) allele polymorphism was 0.75 and 2.25; Glu 42 Lys A allele polymorphism was 9.0 and 1.5, in groups II and III, respectively. None of the MC4R mutations were found in high-socioeconomic school and in control groups. Our data indicated that MC4R polymorphisms were more frequent both in clinical pediatric obese group and in low-socioeconomic school group. In addition, our data revealed that carrying the polymorphism may increase the hereditary form of obesity.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/melanocortin-4-receptor/melanocortin-4-receptor-polymorphisms-in-turkish-pediatric-obese-patients.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TNF-alpha promoter polymorphisms in multiple sclerosis: no association with -308 and -238 alleles, but the -857 alleles in associated with the disease in Turkish patients.</title>
		<link>http://polymorphisms.info/multiple-sclerosis/tnf-alpha-promoter-polymorphisms-in-multiple-sclerosis-no-association-with-308-and-238-alleles-but-the-857-alleles-in-associated-with-the-disease-in-turkish-patients.html</link>
		<comments>http://polymorphisms.info/multiple-sclerosis/tnf-alpha-promoter-polymorphisms-in-multiple-sclerosis-no-association-with-308-and-238-alleles-but-the-857-alleles-in-associated-with-the-disease-in-turkish-patients.html#comments</comments>
		<pubDate>Thu, 25 Feb 2010 20:04:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Multiple sclerosis]]></category>
		<category><![CDATA[Akcali]]></category>
		<category><![CDATA[Akgul]]></category>
		<category><![CDATA[correlation]]></category>
		<category><![CDATA[cytokine]]></category>
		<category><![CDATA[Dysregulation]]></category>
		<category><![CDATA[expression]]></category>
		<category><![CDATA[factor]]></category>
		<category><![CDATA[Gaziantep]]></category>
		<category><![CDATA[Genotyping]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Neurology]]></category>
		<category><![CDATA[PCR-RFLP]]></category>
		<category><![CDATA[Pehlivan]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[proinflammatory]]></category>
		<category><![CDATA[promoter]]></category>
		<category><![CDATA[region]]></category>
		<category><![CDATA[School]]></category>
		<category><![CDATA[sex]]></category>
		<category><![CDATA[TNF]]></category>
		<category><![CDATA[TNF-alpha]]></category>
		<category><![CDATA[tumour]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[University]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=306</guid>
		<description><![CDATA[Akcali A, Pehlivan S, Pehlivan M, Sever T, Akgul P, Neyal M.
Department of Neurology, Gaziantep University School of Medicine, Gaziantep, Turkey.
Summary Dysregulation in the expression of pro- and anti-inflammatory cytokines is one of the milestones in multiple sclerosis (MS) development and progression. Tumour necrosis factor (TNF-alpha), a proinflammatory cytokine is believed to play an important [...]]]></description>
			<content:encoded><![CDATA[<p>Akcali A, Pehlivan S, Pehlivan M, Sever T, Akgul P, Neyal M.</p>
<p>Department of Neurology, Gaziantep University School of Medicine, Gaziantep, Turkey.</p>
<p>Summary Dysregulation in the expression of pro- and anti-inflammatory cytokines is one of the milestones in multiple sclerosis (MS) development and progression. Tumour necrosis factor (TNF-alpha), a proinflammatory cytokine is believed to play an important role in MS pathogenesis. The objective of this study is to investigate the association between TNF-alpha promoter region (TNF-alpha-238, -308 and -857) and susceptibility to MS and clinical course of the disease. Eighty-six relapsing remitting MS patients and 150 sex-, age- and ethnic-matched controls were enrolled in the study. Genotyping was performed by PCR-RFLP method. We observed a statistically significant increase in TNF-alpha 857 CC genotype in MS patients than controls (P &lt; 0.001) while TNF-alpha 857 CT genotype showed a significant negative correlation with MS patients (P = 0.033). No differences in the distribution of the TNF-alpha-238 and -308 alleles were observed. None of the three polymorphisms (-238, -308 and -857) did not show relation with disease duration, Expanded Disability Status Scale or age of onset. On the other hand, significant difference of TNF -857 CC genotype was identified with the low disease index (P = 0.025). Although the study group is small, the results indicate that TNF-alpha 857 CC genotype may cause susceptibility to MS in the Turkish population.</p>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/multiple-sclerosis/tnf-alpha-promoter-polymorphisms-in-multiple-sclerosis-no-association-with-308-and-238-alleles-but-the-857-alleles-in-associated-with-the-disease-in-turkish-patients.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Association between mannose-binding lectin levels and gene polymorphisms in chronic periodontitis and response to treatment.</title>
		<link>http://polymorphisms.info/polymorphisms/chronic-periodontitis/association-between-mannose-binding-lectin-levels-and-gene-polymorphisms-in-chronic-periodontitis-and-response-to-treatment.html</link>
		<comments>http://polymorphisms.info/polymorphisms/chronic-periodontitis/association-between-mannose-binding-lectin-levels-and-gene-polymorphisms-in-chronic-periodontitis-and-response-to-treatment.html#comments</comments>
		<pubDate>Thu, 25 Feb 2010 20:02:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Chronic periodontitis]]></category>
		<category><![CDATA[allele]]></category>
		<category><![CDATA[Arch]]></category>
		<category><![CDATA[association]]></category>
		<category><![CDATA[Berdeli]]></category>
		<category><![CDATA[chronic periodontitis ELISA]]></category>
		<category><![CDATA[codon]]></category>
		<category><![CDATA[Dentistry]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[Distribution]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[exon]]></category>
		<category><![CDATA[fragment]]></category>
		<category><![CDATA[Genomic]]></category>
		<category><![CDATA[immunosorbent]]></category>
		<category><![CDATA[Izmir]]></category>
		<category><![CDATA[Köse]]></category>
		<category><![CDATA[method]]></category>
		<category><![CDATA[Nalbantsoy]]></category>
		<category><![CDATA[Oral Biol]]></category>
		<category><![CDATA[outcome]]></category>
		<category><![CDATA[Ozçaka]]></category>
		<category><![CDATA[PCR-RFLP]]></category>
		<category><![CDATA[Periodontology]]></category>
		<category><![CDATA[plasma]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[response]]></category>
		<category><![CDATA[therapy]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[University]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=304</guid>
		<description><![CDATA[Arch Oral Biol. 2010 Feb 2.
Ozçaka O, Bıçakcı N, Nalbantsoy A, Köse T, Berdeli A.
Department of Periodontology, School of Dentistry, University of Ege, Izmir, Turkey.

BACKGROUND: The aims of the present study were: (1) to investigate mannose-binding lectin (MBL) gene exon-1 polymorphisms in Turkish subjects with chronic periodontitis (CP), (2) to assess the association between these [...]]]></description>
			<content:encoded><![CDATA[<p>Arch Oral Biol. 2010 Feb 2.</p>
<p>Ozçaka O, Bıçakcı N, Nalbantsoy A, Köse T, Berdeli A.</p>
<p>Department of Periodontology, School of Dentistry, University of Ege, Izmir, Turkey.</p>
<div>
<p>BACKGROUND: The aims of the present study were: (1) to investigate mannose-binding lectin (MBL) gene exon-1 polymorphisms in Turkish subjects with chronic periodontitis (CP), (2) to assess the association between these polymorphisms and plasma MBL levels, (3) to determine the effects of MBL genotypes on the outcomes of non-surgical periodontal therapy. METHODS: A total of 172 subjects were included in the present study. Genomic DNA was obtained from the peripheral blood of 83 CP patients and 89 periodontally healthy subjects. The MBL levels were measured by enzyme-linked immunosorbent assay (ELISA). The MBL gene exon-1 polymorphisms were genotyped by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. RESULTS: Subjects homozygous for the frequent allele A had higher MBL plasma levels compared with rare allele B carriers. This difference in MBL plasma levels was statistically significant both in CP patients and healthy subjects. The distribution of MBL gene codon 54 genotypes and allele frequencies did not differ significantly between study groups. All study subjects were the MBL gene codon 52 and 57 frequent allele A carriers. Codon 54 B allele carriers had similar clinical periodontal parameters compared with AA genotypes after non-surgical periodontal therapy. CONCLUSIONS: The present study failed to find any significant association between the MBL gene codon 54 polymorphisms and severe CP in a Turkish population. MBL gene rare allele carriers had lower MBL plasma levels in both study groups. It seems that MBL gene codon 54 B allele carriage may not influence the outcome of periodontal therapy. Copyright © 2010. Published by Elsevier Ltd.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/polymorphisms/chronic-periodontitis/association-between-mannose-binding-lectin-levels-and-gene-polymorphisms-in-chronic-periodontitis-and-response-to-treatment.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vascular endothelial growth factor +405 C/G polymorphism is highly associated with an increased risk of endometriosis in Turkish women.</title>
		<link>http://polymorphisms.info/cancer-kanser/kategorisiz/vascular-endothelial-growth-factor-405-cg-polymorphism-is-highly-associated-with-an-increased-risk-of-endometriosis-in-turkish-women.html</link>
		<comments>http://polymorphisms.info/cancer-kanser/kategorisiz/vascular-endothelial-growth-factor-405-cg-polymorphism-is-highly-associated-with-an-increased-risk-of-endometriosis-in-turkish-women.html#comments</comments>
		<pubDate>Fri, 05 Feb 2010 20:43:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Kategorilenmemiş]]></category>
		<category><![CDATA[allele]]></category>
		<category><![CDATA[altinkaya]]></category>
		<category><![CDATA[altinkayaozlem]]></category>
		<category><![CDATA[Arch]]></category>
		<category><![CDATA[chi square]]></category>
		<category><![CDATA[CONCLUSIONS]]></category>
		<category><![CDATA[Demographic]]></category>
		<category><![CDATA[difference]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[Education]]></category>
		<category><![CDATA[endometrial]]></category>
		<category><![CDATA[Endometriosis]]></category>
		<category><![CDATA[evidence]]></category>
		<category><![CDATA[extraction]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Gungor]]></category>
		<category><![CDATA[hospital]]></category>
		<category><![CDATA[Nominal]]></category>
		<category><![CDATA[OBJECTIVE]]></category>
		<category><![CDATA[Pearson Chi-square]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[restriction]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[Tahir Burak]]></category>
		<category><![CDATA[uterine]]></category>
		<category><![CDATA[vascular]]></category>
		<category><![CDATA[Women]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=299</guid>
		<description><![CDATA[Arch Gynecol Obstet. 2009 Dec 30. 
Altinkaya SO, Ugur M, Ceylaner G, Ozat M, Gungor T, Ceylaner S.
Department of Infertility, Zekai Tahir Burak Women&#8217;s Health Care Education and Research Hospital, Ankara, Turkey, altinkayaozlem@yahoo.com.

OBJECTIVE: Endometriosis is a chronic gynecological disease characterized by the growth of hormonally responsive, endometrial tissue outside the uterine cavity. The present study aims [...]]]></description>
			<content:encoded><![CDATA[<p>Arch Gynecol Obstet. 2009 Dec 30. </p>
<p>Altinkaya SO, Ugur M, Ceylaner G, Ozat M, Gungor T, Ceylaner S.</p>
<p>Department of Infertility, Zekai Tahir Burak Women&#8217;s Health Care Education and Research Hospital, Ankara, Turkey, altinkayaozlem@yahoo.com.</p>
<div>
<p>OBJECTIVE: Endometriosis is a chronic gynecological disease characterized by the growth of hormonally responsive, endometrial tissue outside the uterine cavity. The present study aims to analyze two vascular endothelial growth factor (VEGF) polymorphisms (-460 C/T and +405 C/G) in Turkish women with and without endometriosis. STUDY DESIGN: A case-control study was undertaken at the Infertility Department of Zekai Tahir Burak Women&#8217;s Health Care Education and Research Hospital. The single nucleotide polymorphisms, -460 C/T and +405 C/G, in the 5&#8242;-untranslated region of the VEGF gene were tested in 98 affected women and 94 women with no laparoscopic evidence of disease. Endometriosis was also confirmed histologically. Following genomic extraction of genomic DNA, genotyping of the -460 C/T and +405 C/G polymorphisms of the VEGF gene were performed by polymerase chain reaction and restriction fragment length polymorphism assay. Nominal data were evaluated by Pearson Chi-square or Fisher&#8217;s Exact test, where applicable. Odds ratios and 95% confidence intervals were also calculated. A P value less than 0.05 was considered statistically significant. RESULTS: Demographic data were similar among groups. The genotype and allele frequencies of the -460 C/T polymorphism did not differ significantly between cases and controls. In contrast, the genotype (P &lt; 0.001) and allele frequencies (P &lt; 0.001) of +405 C/G polymorphism showed a significant difference between cases and controls. Regardless of the early or advanced stage, women with endometriosis showed a higher incidence of the +405 GC genotype and +405G allele when compared with the controls. CONCLUSIONS: These data suggest that VEGF +405 GC genotype and +405G allele may be associated with the risk of developing early and advanced stage endometriosis in the Turkish population.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/cancer-kanser/kategorisiz/vascular-endothelial-growth-factor-405-cg-polymorphism-is-highly-associated-with-an-increased-risk-of-endometriosis-in-turkish-women.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>677C&gt;T and 1298A&gt;C Polymorphisms of Methylenetetrahydropholate Reductase Gene and Biochemical Parameters in Turkish Population with Spina Bifida Occulta.</title>
		<link>http://polymorphisms.info/gene-polymorphisms/methylenetetrahydropholate-reductase/677ct-and-1298ac-polymorphisms-of-methylenetetrahydropholate-reductase-gene-and-biochemical-parameters-in-turkish-population-with-spina-bifida-occulta.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/methylenetetrahydropholate-reductase/677ct-and-1298ac-polymorphisms-of-methylenetetrahydropholate-reductase-gene-and-biochemical-parameters-in-turkish-population-with-spina-bifida-occulta.html#comments</comments>
		<pubDate>Fri, 05 Feb 2010 20:40:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Methylenetetrahydropholate Reductase]]></category>
		<category><![CDATA[Aslan]]></category>
		<category><![CDATA[Biochemical]]></category>
		<category><![CDATA[Buyukbas]]></category>
		<category><![CDATA[C MTHFR]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[erdogan]]></category>
		<category><![CDATA[Faculty]]></category>
		<category><![CDATA[folate]]></category>
		<category><![CDATA[frequency]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[homocysteine]]></category>
		<category><![CDATA[homozygosity]]></category>
		<category><![CDATA[M. Selcuk]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Meram]]></category>
		<category><![CDATA[Methylenetetrahydropholate]]></category>
		<category><![CDATA[Neurosurg]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[serum]]></category>
		<category><![CDATA[Solak]]></category>
		<category><![CDATA[Turk]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[University]]></category>
		<category><![CDATA[vitamin]]></category>
		<category><![CDATA[Yildiz]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=296</guid>
		<description><![CDATA[Turk Neurosurg. 2010 Jan;20(1):9-15.
Eser B, Cosar M, Eser O, Erdogan MO, Aslan A, Yildiz H, Boyaci G, Buyukbas S, Solak M.
Selcuk University, Meram Faculty of Medicine, Department of Medical Genetics, Konya, Turkey.

AIM: This study aimed to investigate the 677C &#62; T and 1298A &#62; C MTHFR gene polymorphisms and their metabolic effects on the levels [...]]]></description>
			<content:encoded><![CDATA[<p>Turk Neurosurg. 2010 Jan;20(1):9-15.</p>
<p>Eser B, Cosar M, Eser O, Erdogan MO, Aslan A, Yildiz H, Boyaci G, Buyukbas S, Solak M.</p>
<p>Selcuk University, Meram Faculty of Medicine, Department of Medical Genetics, Konya, Turkey.</p>
<div>
<p>AIM: This study aimed to investigate the 677C &gt; T and 1298A &gt; C MTHFR gene polymorphisms and their metabolic effects on the levels of folate, vitamin B12 and homocysteine in the serum of Turkish spina bifida occulta (SBO) patients and healthy individuals in disease. MATERIAL and METHODS: A case-control study was performed to detect 677C &gt; T and 1298A &gt; C MTHFR gene polymorphisms in 39 SBO patients and 34 healthy individuals. The folate, vitamin B12 and homocysteine concentrations in the serum of SBO and healthy individuals were evaluated and compared with MTHFR gene polymorphisms. RESULTS: 677 CC/CT/TT MTHFR genotype frequency differences between the SBO patients and controls were not significant (x(2)=3.325, P=0.068; x(2)=1.479, P=0.224; x(2)=0.275, P=0.600; respectively). 1298A &gt; C MTHFR genotype frequency differences between the SBO patients and controls were significant (x(2)=8.477, P=0.004). The frequencies of the Aand C alleles of the 1298A &gt; C polymorphism did not differ in a statistically significant manner between the groups (x(2)=0.576, P=0.448). The biochemical parameters were not significantly different between SBO patients and healthy individuals (P &gt; 0.05). CONCLUSION: The 677C &gt; T and 1298A &gt; C polymorphisms of the MTHFR gene cannot be regarded as major risk factors for SBO in the Turkish patients 677TT homozygosity may affect the metabolism of homocysteine.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/methylenetetrahydropholate-reductase/677ct-and-1298ac-polymorphisms-of-methylenetetrahydropholate-reductase-gene-and-biochemical-parameters-in-turkish-population-with-spina-bifida-occulta.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Angiotensin-Converting Enzyme Gene Polymorphism in Overweight and Obese Turkish Patients with Insulin Resistance.</title>
		<link>http://polymorphisms.info/polymorphisms/angiotensin-converting-enzyme-gene-polymorphism-in-overweight-and-obese-turkish-patients-with-insulin-resistance.html</link>
		<comments>http://polymorphisms.info/polymorphisms/angiotensin-converting-enzyme-gene-polymorphism-in-overweight-and-obese-turkish-patients-with-insulin-resistance.html#comments</comments>
		<pubDate>Fri, 05 Feb 2010 20:37:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[ACE]]></category>
		<category><![CDATA[amplification]]></category>
		<category><![CDATA[Angiotensin]]></category>
		<category><![CDATA[Bastemir]]></category>
		<category><![CDATA[Biol]]></category>
		<category><![CDATA[Cell]]></category>
		<category><![CDATA[control]]></category>
		<category><![CDATA[Converting]]></category>
		<category><![CDATA[deletion]]></category>
		<category><![CDATA[Denizli]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[Endocrinology]]></category>
		<category><![CDATA[enzyme]]></category>
		<category><![CDATA[frequency]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[gene polymorphism]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Guclu]]></category>
		<category><![CDATA[Karasu]]></category>
		<category><![CDATA[Kursunluoglu]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[metabolism]]></category>
		<category><![CDATA[Overweight]]></category>
		<category><![CDATA[Pamukkale]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[reaction]]></category>
		<category><![CDATA[resistance]]></category>
		<category><![CDATA[Turgut]]></category>
		<category><![CDATA[University]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=293</guid>
		<description><![CDATA[DNA Cell Biol. 2010 Jan 13.
Akin F, Turgut S, Bastemir M, Turgut G, Kursunluoglu R, Karasu U, Guclu A.
1 Department of Endocrinology and Metabolism, Faculty of Medicine, Pamukkale University , Denizli, Turkey .

The aim of this study was to analyze the distribution of the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene in obese [...]]]></description>
			<content:encoded><![CDATA[<p>DNA Cell Biol. 2010 Jan 13.</p>
<p>Akin F, Turgut S, Bastemir M, Turgut G, Kursunluoglu R, Karasu U, Guclu A.</p>
<p>1 Department of Endocrinology and Metabolism, Faculty of Medicine, Pamukkale University , Denizli, Turkey .</p>
<div>
<p>The aim of this study was to analyze the distribution of the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene in obese Turkish patients with insulin resistance (IR). Sixty-two obese Turkish patients with IR were enrolled in this study. One hundred healthy people without IR were recruited as the control group. ACE amplification was performed by polymerase chain reaction. The frequency of the DD genotype was significantly higher in obese patients with IR than in control subjects. Of sixty-two patients, 1 (1.6%) had an II genotype, 22 (35.5%) had an ID genotype, and 39 (62.9%) had a DD genotype. The frequency of the I allele in the patient group was significantly lower than in controls. We found that the frequency of the DD genotype was higher in obese Turkish patients with IR. ACE gene I/D polymorphism may be associated with obesity in the Turkish population.</p>
</div>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/polymorphisms/angiotensin-converting-enzyme-gene-polymorphism-in-overweight-and-obese-turkish-patients-with-insulin-resistance.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease.]</title>
		<link>http://polymorphisms.info/paraoxanase-gene/the-relationship-between-paraoxanase-gene-leu-met-55-and-gln-arg-192-polymorphisms-and-coronary-artery-disease.html</link>
		<comments>http://polymorphisms.info/paraoxanase-gene/the-relationship-between-paraoxanase-gene-leu-met-55-and-gln-arg-192-polymorphisms-and-coronary-artery-disease.html#comments</comments>
		<pubDate>Wed, 03 Feb 2010 14:47:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Paraoxanase gene]]></category>
		<category><![CDATA[allele frequency]]></category>
		<category><![CDATA[amino acid change]]></category>
		<category><![CDATA[Arch]]></category>
		<category><![CDATA[Berdeli]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[control group]]></category>
		<category><![CDATA[control groups]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[DESIGN]]></category>
		<category><![CDATA[Distribution]]></category>
		<category><![CDATA[enzymes]]></category>
		<category><![CDATA[genet]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Genotypes]]></category>
		<category><![CDATA[Gln]]></category>
		<category><![CDATA[Glu]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymerase chain reaction]]></category>
		<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[PON]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[protein]]></category>
		<category><![CDATA[restriction]]></category>
		<category><![CDATA[restriction enzymes]]></category>
		<category><![CDATA[risk]]></category>
		<category><![CDATA[risk factor]]></category>
		<category><![CDATA[substitution]]></category>
		<category><![CDATA[susceptibility]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=291</guid>
		<description><![CDATA[Turk Kardiyol Dern Ars. 2009;37(7):473-478.
Taşkıran P, Cam SF, Sekuri C, Tüzün N, Alioğlu E, Altıntaş N, Berdeli A.
Department of Medical Biology and Genetics, Medicine Faculty of Celal Bayar University, Manisa, Turkey.
OBJECTIVES: Paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated esterase that hydrolyses lipoperoxides. PON1 serves as a protective factor against oxidative modification of LDL, suggesting that [...]]]></description>
			<content:encoded><![CDATA[<p>Turk Kardiyol Dern Ars. 2009;37(7):473-478.</p>
<p>Taşkıran P, Cam SF, Sekuri C, Tüzün N, Alioğlu E, Altıntaş N, Berdeli A.</p>
<p>Department of Medical Biology and Genetics, Medicine Faculty of Celal Bayar University, Manisa, Turkey.</p>
<p>OBJECTIVES: Paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated esterase that hydrolyses lipoperoxides. PON1 serves as a protective factor against oxidative modification of LDL, suggesting that it may play an important role in the prevention of atherosclerotic process. Research has focused on two polymorphisms: leucine (L allele) to methionine (M allele) substitution at codon 55, and glutamine (A allele) to arginine (B allele) substitution at codon 192. STUDY DESIGN: We examined amino acid changes at codon 55 and 192 in the PON1 gene by polymerase chain reaction and using restriction enzymes in 120 patients (92 men, 28 women; mean age 48.2+/-4.3 years) with premature coronary artery disease (CAD) and in 102 healthy subjects (80 men, 22 women; mean age 46.8+/-5.2 years) with no history of CAD and a normal electrocardiogram. RESULTS: Distribution of genotypes in the patient and control groups at codon 55 were 6.7% and 4.9% for MM, 46.7% and 29.4% for LM, 46.7% and 65.7% for LL, respectively. The frequency of genotypes at codon 192 were as follows: 4.2% and 2% for RR, 40% and 35.3% for QR, and 55.8% and 62.8% for QQ, respectively. While the frequency of PON1 55M allele was higher in the CAD group (0.3 vs. 0.2), PON1 192R allele frequency did not differ (p&gt;0.05). There was a significant relationship between the PON1 M/L55 polymorphism and CAD (p=0.017), whereas the R/Q192 polymorphism was not associated with CAD (p=0.445). CONCLUSION: These data suggest that the PON1 M/L55 polymorphism shows a significant relationship with CAD and the Q/R192 polymorphism is not a major risk factor causing susceptibility to CAD in our population.</p>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/paraoxanase-gene/the-relationship-between-paraoxanase-gene-leu-met-55-and-gln-arg-192-polymorphisms-and-coronary-artery-disease.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey</title>
		<link>http://polymorphisms.info/gene-polymorphisms/interleukin-10-gene-promoter-polymorphism-in-patients-with-schizophrenia-in-a-region-of-east-turkey.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/interleukin-10-gene-promoter-polymorphism-in-patients-with-schizophrenia-in-a-region-of-east-turkey.html#comments</comments>
		<pubDate>Wed, 20 Jan 2010 23:47:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[Interleukin]]></category>
		<category><![CDATA[schizophrenia]]></category>
		<category><![CDATA[Activation]]></category>
		<category><![CDATA[allele]]></category>
		<category><![CDATA[Biol]]></category>
		<category><![CDATA[Biological]]></category>
		<category><![CDATA[Distribution]]></category>
		<category><![CDATA[fragment length polymorphism]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[gene promoter]]></category>
		<category><![CDATA[Genetic]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Genotypes]]></category>
		<category><![CDATA[Genotyping]]></category>
		<category><![CDATA[homozygote]]></category>
		<category><![CDATA[Human]]></category>
		<category><![CDATA[Humans]]></category>
		<category><![CDATA[Ozbey]]></category>
		<category><![CDATA[PCR]]></category>
		<category><![CDATA[polymerase]]></category>
		<category><![CDATA[polymorphic]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[promoter region]]></category>
		<category><![CDATA[Psychiatric]]></category>
		<category><![CDATA[restriction]]></category>
		<category><![CDATA[restriction fragment]]></category>
		<category><![CDATA[restriction fragment length]]></category>
		<category><![CDATA[schizophrenic patients]]></category>
		<category><![CDATA[study]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[turkish population]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=286</guid>
		<description><![CDATA[Author(s): Ozbey U (Ozbey, Ulku)2, Tug E (Tug, Esra)1, Namli M (Namli, Mustafa)3
Source: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY Volume: 10 Issue: 5 Pages: 461-468 Published: 2009
Abstract: Schizophrenia is one of the most severe psychiatric disorders, with a worldwide incidence of 1%. Immunological abnormalities have been found to be associated with schizophrenia for decades. Cytokines are [...]]]></description>
			<content:encoded><![CDATA[<p>Author(s): Ozbey U (Ozbey, Ulku)2, Tug E (Tug, Esra)1, Namli M (Namli, Mustafa)3<br />
Source: WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY Volume: 10 Issue: 5 Pages: 461-468 Published: 2009</p>
<p><strong>Abstract:</strong> Schizophrenia is one of the most severe psychiatric disorders, with a worldwide incidence of 1%. Immunological abnormalities have been found to be associated with schizophrenia for decades. Cytokines are key proteins involved in the immune system activation. Interleukin-10 (IL-10), an important immunoregulatory cytokine, is located on chromosome 1q31 32, a region previously reported to be linked to schizophrenia in genetic studies. In the present study it was aimed to examine the IL-10 gene promoter region&#8217;s polymorphic variants in patients with schizophrenia in a population of the Elazig Region of East Anatolia, Turkey. Polymorphisms at position -1082, -819 and -592 in the IL-10 promoter region were determined in 171 Turkish patients who were diagnosed with schizophrenia, based on the DSM-IV, and 168 healthy controls, by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP). We analyzed allele, genotype, and haplotype distributions using a case-control association study. Genotyping was performed by RFLP. Statistically significant differences were observed in both allelic and genotypic frequencies of the -592A/C polymorphism (Allele, P = 0.034, OR = 1.26, 95% CI 1.02 &#8211; 1.56; Genotype, P = 0.048), while the other two polymorphisms in distribution of the alleles and genotypes in patients with schizophrenia were not significantly different from those of controls (P &gt; 0.05). Our results show a significant increase of GTA homozygotes (the high IL-10-producing haplotype) in schizophrenic patients compared to control subjects (P = 0.0001). These data suggest that the IL-10 gene promoter polymorphism may be one of the susceptibility factors to develop schizophrenia in the Turkish population, and apparently in all humans.<br />
Document Type: Article<br />
Language: English<br />
Author Keywords: Biological psychiatry; cytokines; genetics; polymorphism; schizophrenia<br />
KeyWords Plus: ASSOCIATION; HAPLOTYPES; POPULATION; LINKAGE<br />
Reprint Address: Tug, E (reprint author), Abant Izzet Baysal Univ, Izzet Baysal Med Sch, Dept Med Genet, TR-14280 Bolu, Turkey<br />
Addresses:<br />
1. Abant Izzet Baysal Univ, Izzet Baysal Med Sch, Dept Med Genet, TR-14280 Bolu, Turkey<br />
2. Firat Univ, Fac Med, Dept Med Biol &amp; Genet, TR-23169 Elazig, Turkey<br />
3. Hosp Psychiat, Elazig, Turkey<br />
E-mail Addresses: esratug@hotmail.com</p>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/interleukin-10-gene-promoter-polymorphism-in-patients-with-schizophrenia-in-a-region-of-east-turkey.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Elucidating genetic relationships, diversity and population structure among the Turkish female figs</title>
		<link>http://polymorphisms.info/gene-polymorphisms/elucidating-genetic-relationships-diversity-and-population-structure-among-the-turkish-female-figs.html</link>
		<comments>http://polymorphisms.info/gene-polymorphisms/elucidating-genetic-relationships-diversity-and-population-structure-among-the-turkish-female-figs.html#comments</comments>
		<pubDate>Wed, 20 Jan 2010 23:44:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Gene polymorphisms]]></category>
		<category><![CDATA[analysis]]></category>
		<category><![CDATA[Antalya]]></category>
		<category><![CDATA[Biochem]]></category>
		<category><![CDATA[component]]></category>
		<category><![CDATA[Distribution]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[DNAs]]></category>
		<category><![CDATA[genet]]></category>
		<category><![CDATA[Genetic]]></category>
		<category><![CDATA[genome]]></category>
		<category><![CDATA[genotype]]></category>
		<category><![CDATA[Genotypes]]></category>
		<category><![CDATA[Med]]></category>
		<category><![CDATA[Mediterranean]]></category>
		<category><![CDATA[Molecular]]></category>
		<category><![CDATA[PCa]]></category>
		<category><![CDATA[polymorphic]]></category>
		<category><![CDATA[polymorphism]]></category>
		<category><![CDATA[polymorphisms]]></category>
		<category><![CDATA[population]]></category>
		<category><![CDATA[populations]]></category>
		<category><![CDATA[relationship]]></category>
		<category><![CDATA[RFLP]]></category>
		<category><![CDATA[sequence]]></category>
		<category><![CDATA[Turkey]]></category>

		<guid isPermaLink="false">http://polymorphisms.info/?p=284</guid>
		<description><![CDATA[Ikten H (Ikten, Hatice)2, Mutlu N (Mutlu, Nedim)3, Gulsen O (Gulsen, Osman)1, Kocatas H (Kocatas, Hilmi)4, Aksoy U (Aksoy, Uygun)5  
Source: GENETICA    Volume: 138    Issue: 2    Pages: 169-177    Published: FEB 2010    
 Abstract: A collection of 96 female Turkish [...]]]></description>
			<content:encoded><![CDATA[<p>Ikten H (Ikten, Hatice)2, Mutlu N (Mutlu, Nedim)3, Gulsen O (Gulsen, Osman)1, Kocatas H (Kocatas, Hilmi)4, Aksoy U (Aksoy, Uygun)5  </p>
<p>Source: GENETICA    Volume: 138    Issue: 2    Pages: 169-177    Published: FEB 2010    </p>
<p> Abstract: A collection of 96 female Turkish fig (Ficus carica L.) accessions was studied to elucidate genetic structure and estimate diversity and genetic similarity distribution among the female figs present in Turkish genetic resources, using 157 molecular genome markers including 129 sequence-related amplified polymorphisms, 21 random amplified polymorphic DNAs, and 7 simple-sequence repeats. The plant samples mainly included Turkish fig collections selected throughout the country over the course of a half-century. Neighbor-joining analysis revealed continuous dissimilarity range, and it was difficult to classify figs into distinct groups. The principle component analysis produced similar results. The analysis of molecular variance indicated that 95 and 93% of genetic variation were explained by within geographic origins and similar fruit rind color, respectively. Sub-structuring Bayesian analysis assigned the 96 female figs into four sub-populations, and indicated that they were highly related. The corrected allelic pairwise distances among the six geographic origins were less than 5%. This study suggests that geography- and color-based groups were not genetically distinct among the Turkish figs.<br />
Document Type: Article<br />
Language: English<br />
Author Keywords: Ficus carica; SRAP; Neighbor-joining; PCA; AMOVA; Population structure<br />
KeyWords Plus: FICUS-CARICA L.; GERMPLASM COLLECTION; COMMON FIG; MARKERS; RAPD; RELATEDNESS; GENOTYPES; RFLP; AFLP<br />
Reprint Address: Gulsen, O (reprint author), Erciyes Univ, Dept Hort, Fac Agr, TR-38039 Kayseri, Turkey<br />
Addresses:<br />
1. Erciyes Univ, Dept Hort, Fac Agr, TR-38039 Kayseri, Turkey<br />
2. Minist Agr &#038; Rural Affairs, W Mediterranean Res Inst, TR-07100 Antalya, Turkey<br />
3. Univ Nebraska, George W Beadle Ctr, Dept Biochem, Lincoln, NE 68503 USA<br />
4. Fig Res Inst, TR-09600 Erbeyli, Aydin Turkey<br />
5. Aegean Univ, Fac Agr, Dept Hort, TR-35100 Izmir, Turkey<br />
E-mail Addresses: o_gulsen@yahoo.com  </p>
]]></content:encoded>
			<wfw:commentRss>http://polymorphisms.info/gene-polymorphisms/elucidating-genetic-relationships-diversity-and-population-structure-among-the-turkish-female-figs.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

